Literature DB >> 16227113

Nutritional management of urea cycle disorders.

Rani H Singh1, William J Rhead, Wendy Smith, Brendan Lee, Lisa Sniderman King, Marshall Summar.   

Abstract

Nutritional management of patients who have urea cycle disorders is one of the most challenging tasks in clinical nutrition. The degree to which protein intake should be restricted in urea cycle disorders requires complex calculations which depend on many variables such as specific enzyme defect, age-related growth rate, current health status, level of physical activity, amount of free amino acids administered, energy intake, residual urea cycle function, family lifestyle, use of nitrogen-scavenging medications, and the patient's eating behaviors. This paper presents two case histories and a series of recommendations outlining the nutrition management of urea cycle disorders. It also identifies difficulties that arise in the course of treatment, and suggests practical solutions for overcoming them.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227113     DOI: 10.1016/j.ccc.2005.08.003

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  15 in total

1.  Two hypomorphic alleles of mouse Ass1 as a new animal model of citrullinemia type I and other hyperammonemic syndromes.

Authors:  Carlos J Perez; Jean Jaubert; Jean-Louis Guénet; Kirstin F Barnhart; Catherine M Ross-Inta; Vicente C Quintanilla; Isabelle Aubin; Jimi L Brandon; Nancy W Otto; John DiGiovanni; Irma Gimenez-Conti; Cecilia Giulivi; Donna F Kusewitt; Claudio J Conti; Fernando Benavides
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

Review 2.  Nutritional management of patients with urea cycle disorders.

Authors:  R H Singh
Journal:  J Inherit Metab Dis       Date:  2007-11-25       Impact factor: 4.982

Review 3.  Laboratory diagnostic approaches in metabolic disorders.

Authors:  Ruben Bonilla Guerrero; Denise Salazar; Pranoot Tanpaiboon
Journal:  Ann Transl Med       Date:  2018-12

Review 4.  Inherited Metabolic Disorders: Aspects of Chronic Nutrition Management.

Authors:  Suzanne W Boyer; Lisa J Barclay; Lindsay C Burrage
Journal:  Nutr Clin Pract       Date:  2015-06-16       Impact factor: 3.080

5.  Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.

Authors:  Claudia I Chapuy; Inderneel Sahai; Rohit Sharma; Andrew X Zhu; Olga N Kozyreva
Journal:  Oncologist       Date:  2016-03-14

6.  Computational modeling to predict nitrogen balance during acute metabolic decompensation in patients with urea cycle disorders.

Authors:  Erin L MacLeod; Kevin D Hall; Peter J McGuire
Journal:  J Inherit Metab Dis       Date:  2015-08-11       Impact factor: 4.982

7.  Acute hyperammonemic encephalopathy in adult onset ornithine transcarbamylase deficiency.

Authors:  Ogee Mer Panlaqui; Khoa Tran; Amanda Johns; Jim McGill; Hayden White
Journal:  Intensive Care Med       Date:  2008-07-24       Impact factor: 17.440

8.  Infectious precipitants of acute hyperammonemia are associated with indicators of increased morbidity in patients with urea cycle disorders.

Authors:  Peter J McGuire; Hye-Seung Lee; Marshall L Summar
Journal:  J Pediatr       Date:  2013-09-29       Impact factor: 4.406

Review 9.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

10.  Acute metabolic decompensation due to influenza in a mouse model of ornithine transcarbamylase deficiency.

Authors:  Peter J McGuire; Tatiana N Tarasenko; Tony Wang; Ezra Levy; Patricia M Zerfas; Thomas Moran; Hye Seung Lee; Brian J Bequette; George A Diaz
Journal:  Dis Model Mech       Date:  2013-11-21       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.